258 related articles for article (PubMed ID: 8105119)
1. Chromosome 3p deletion in a renal cell carcinoma cell line established from a patient with von Hippel-Lindau disease.
Kohno T; Sekine T; Tobisu K; Oshimura M; Yokota J
Jpn J Clin Oncol; 1993 Aug; 23(4):226-31. PubMed ID: 8105119
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetic studies of sporadic and familial renal cell carcinoma.
Gnarra JR; Glenn GM; Latif F; Anglard P; Lerman MI; Zbar B; Linehan WM
Urol Clin North Am; 1993 May; 20(2):207-16. PubMed ID: 8098558
[TBL] [Abstract][Full Text] [Related]
3. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
[TBL] [Abstract][Full Text] [Related]
4. Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location.
Maranchie JK; Afonso A; Albert PS; Kalyandrug S; Phillips JL; Zhou S; Peterson J; Ghadimi BM; Hurley K; Riss J; Vasselli JR; Ried T; Zbar B; Choyke P; Walther MM; Klausner RD; Linehan WM
Hum Mutat; 2004 Jan; 23(1):40-6. PubMed ID: 14695531
[TBL] [Abstract][Full Text] [Related]
5. Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis.
Gnarra JR; Lerman MI; Zbar B; Linehan WM
Semin Oncol; 1995 Feb; 22(1):3-8. PubMed ID: 7855617
[TBL] [Abstract][Full Text] [Related]
6. Frequent allelic loss at chromosome arm 3p is distinct from genetic alterations of the Von-Hippel Lindau tumor suppressor gene in head and neck cancer.
Waber PG; Lee NK; Nisen PD
Oncogene; 1996 Jan; 12(2):365-9. PubMed ID: 8570213
[TBL] [Abstract][Full Text] [Related]
7. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
[TBL] [Abstract][Full Text] [Related]
8. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.
Seizinger BR; Rouleau GA; Ozelius LJ; Lane AH; Farmer GE; Lamiell JM; Haines J; Yuen JW; Collins D; Majoor-Krakauer D
Nature; 1988 Mar; 332(6161):268-9. PubMed ID: 2894613
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity on 3p in a renal cell carcinoma in von Hippel-Lindau syndrome.
Decker HJ; Gemmill RM; Neumann HP; Walter TA; Sandberg AA
Cancer Genet Cytogenet; 1989 Jun; 39(2):289-93. PubMed ID: 2568884
[TBL] [Abstract][Full Text] [Related]
11. A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma.
Yamakawa K; Morita R; Takahashi E; Hori T; Ishikawa J; Nakamura Y
Cancer Res; 1991 Sep; 51(17):4707-11. PubMed ID: 1678685
[TBL] [Abstract][Full Text] [Related]
12. Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens.
Zhuang Z; Gnarra JR; Dudley CF; Zbar B; Linehan WM; Lubensky IA
Mod Pathol; 1996 Aug; 9(8):838-42. PubMed ID: 8871925
[TBL] [Abstract][Full Text] [Related]
13. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
14. Juvenile renal cell carcinoma as first manifestation of von Hippel-Lindau disease.
Granata A; Sessa A; Righetti M; Cordaro S; Leone G; Figura M; Fatuzzo P; Rapisarda F; Di Maria E; Ciotti P; Mandich P; Nardo A; Ferrone M; Gallone S; Liuzzo G
J Nephrol; 2004; 17(2):306-10. PubMed ID: 15293534
[TBL] [Abstract][Full Text] [Related]
15. Terminal deletion of chromosome 3p sequences in nonpapillary renal cell carcinomas: a breakpoint cluster between loci D3S1285 and D3S1603.
Wilhelm M; Bugert P; Kenck C; Staehler G; Kovacs G
Cancer Res; 1995 Nov; 55(22):5383-5. PubMed ID: 7585605
[TBL] [Abstract][Full Text] [Related]
16. Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas.
Kenck C; Wilhelm M; Bugert P; Staehler G; Kovacs G
J Pathol; 1996 Jun; 179(2):157-61. PubMed ID: 8758207
[TBL] [Abstract][Full Text] [Related]
17. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
[TBL] [Abstract][Full Text] [Related]
18. Multifocal bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: identification of a new germline mutation.
Sessa A; Battini G; Meroni M; Pitingolo F; Righetti M; Ciotti P; Di Maria E; Bellone E; Ajmar F; Mandich P
J Nephrol; 2005; 18(2):209-12. PubMed ID: 15931650
[TBL] [Abstract][Full Text] [Related]
19. [Von Hippel-Lindau disease and renal cancer: 10 years of genetic progress. GEFVHL (French-Speaking Study Group on von Hippel-Lindau disease)].
Richard S; Beroud C; Joly D; Chretien Y; Benoit G
Prog Urol; 1998 Jun; 8(3):330-9. PubMed ID: 9689663
[TBL] [Abstract][Full Text] [Related]
20. Genetics of renal cell carcinoma.
Daniel LN; Linehan WM
Semin Urol; 1989 Nov; 7(4):258-63. PubMed ID: 2575784
[No Abstract] [Full Text] [Related]
[Next] [New Search]